353 related articles for article (PubMed ID: 21787318)
1. Assessing the contribution of inflammation in models of Alzheimer's disease.
Johnston H; Boutin H; Allan SM
Biochem Soc Trans; 2011 Aug; 39(4):886-90. PubMed ID: 21787318
[TBL] [Abstract][Full Text] [Related]
2. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
Weisman D; Hakimian E; Ho GJ
Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
[TBL] [Abstract][Full Text] [Related]
3. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
4. The role of inflammation in Alzheimer's disease.
Tuppo EE; Arias HR
Int J Biochem Cell Biol; 2005 Feb; 37(2):289-305. PubMed ID: 15474976
[TBL] [Abstract][Full Text] [Related]
5. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease.
Gasparini L; Ongini E; Wilcock D; Morgan D
Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679
[TBL] [Abstract][Full Text] [Related]
6. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
7. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Walker DG; Lue LF
J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
[TBL] [Abstract][Full Text] [Related]
8. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology.
van Groen T; Kadish I
Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation.
Koistinaho M; Kettunen MI; Goldsteins G; Keinänen R; Salminen A; Ort M; Bures J; Liu D; Kauppinen RA; Higgins LS; Koistinaho J
Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1610-5. PubMed ID: 11818564
[TBL] [Abstract][Full Text] [Related]
10. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
[TBL] [Abstract][Full Text] [Related]
11. Clinical aspects of inflammation in Alzheimer's disease.
Rosenberg PB
Int Rev Psychiatry; 2005 Dec; 17(6):503-14. PubMed ID: 16401549
[TBL] [Abstract][Full Text] [Related]
12. Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer's disease.
Ferretti MT; Bruno MA; Ducatenzeiler A; Klein WL; Cuello AC
Neurobiol Aging; 2012 Jul; 33(7):1329-42. PubMed ID: 21414686
[TBL] [Abstract][Full Text] [Related]
13. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
Koistinaho M; Koistinaho J
Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
[TBL] [Abstract][Full Text] [Related]
14. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
15. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of microglia accumulation in Alzheimer's disease: therapeutic implications.
El Khoury J; Luster AD
Trends Pharmacol Sci; 2008 Dec; 29(12):626-32. PubMed ID: 18835047
[TBL] [Abstract][Full Text] [Related]
17. Microglia as a potential bridge between the amyloid beta-peptide and tau.
Kitazawa M; Yamasaki TR; LaFerla FM
Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
[TBL] [Abstract][Full Text] [Related]
18. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
Malm TM; Koistinaho M; Pärepalo M; Vatanen T; Ooka A; Karlsson S; Koistinaho J
Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for Alzheimer's disease.
McGeer PL; McGeer E
Sci Aging Knowledge Environ; 2004 Jul; 2004(27):pe29. PubMed ID: 15243154
[TBL] [Abstract][Full Text] [Related]
20. Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.
Bamberger ME; Landreth GE
Microsc Res Tech; 2001 Jul; 54(2):59-70. PubMed ID: 11455613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
